Ep Global Communicat (EPGL) 0.0276 $EPGL EPGL Smart

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ep Global Communicat (EPGL) 0.0276 $EPGL

EPGL Smart Contact Lens Technology Is Attracting 'Giants' of the Industry
PR Newswire - Thu Apr 07, 7:15AM CDT
EP Global Communications, Inc. (Public OTC: EPGL). Since Announcing Settlement with CooperVision, Inc., at the beginning of 2016, in which EPGL gained full ownership of its pending patents, EPGL management has been receiving inquiries from major industry titans. The Company is now negotiating its first new relationships since that time while continuing to progress its pending patents. To that end, EPGL has filed the latest in a series of patents pending in the hot new field of smart contact lens technology. The latest filing is for an optic display mechanism within the contact lens which could lay a new foundation for augmented reality (AR) in the field of vision. The original US provisional version of this patent was filed over a year ago and the new PCT filing is not yet public. "The major difference with EPGL's technology and the competition thus far is that we are the only company to publicly show our electronic circuitry material in a photo; which has been proven to integrate distortion free into real silicone hydrogel contact lenses," said Michael Hayes, President of EPGL. "That's a big deal considering our competition is Google, Facebook and Samsung to name a few. EPGL is a major player given some of our pending patents," Hayes added.

EP Global Communications, Inc. Reaches Settlement Agreement with CooperVision, Inc.
PR Newswire - Thu Jan 07, 2:34PM CST
EP Global Communications, Inc. (Public OTC: EPGL)

EPGL Invents the "Smart Case" for Contact Lenses
PR Newswire - Mon Aug 03, 9:23PM CDT
EP Global Communications, Inc. (OTC: EPGL). In the past month, EPGL has been contacted by several Investment firms and some of Silicon Valley's venture capital firms even though EPGL is not currently seeking venture capital. Why is this?

Google, Novartis and EPGL in Race to Develop First "Autofocus" Contact Lens
PR Newswire - Wed Jul 22, 7:05AM CDT
EP Global Communications, Inc. (Public OTC: EPGL)
NVS: 75.11 (-0.11)

CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B
PR Newswire - Mon Mar 30, 12:11PM CDT
EP Global Communications, Inc. (OTC-PINK: EPGL) In a new material development to shareholders, EPGL has opened negotiations with CooperVision, Inc. at $1.1 billion for the exclusive Option to License their new ophthalmic technologies. As previously disclosed publicly, CooperVision, Inc. and EP Global Communications, Inc. have co-developed new contact lens technologies, which has led to several new patent filings. It is estimated by some industry experts that just one of these newly developed technologies could add $5 billion annually to contact lens sales worldwide.

CooperVision, Inc. Asks EP Global Communications, Inc. to Grant Option to License Immediately
PR Newswire - Mon Mar 16, 11:45AM CDT
EP Global Communications, Inc. (OTC-PINK: EPGL) announces new material developments. It was previously disclosed publicly in 2014 that EPGL and CooperVision, Inc. (COO NYSE The Cooper Companies Inc.) were engaged in a Development Agreement for new ophthalmic and medical technologies.
COO: 154.95 (-0.26)

Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015
PR Newswire - Fri Dec 05, 2:05AM CST
IRVINE, Calif., Dec. 5, 2014 /PRNewswire/-- EP Global Communications, Inc. (OTC-PINK: EPGL) and Pricewaterhouse Coopers Caymans Ltd. (PwC) have entered an Agreement to mutually reduce their outstanding common share count by retiring a significant number of shares managed by PwC and matching shares held by Michael Hayes, Company President. The plan will be executed on January 30, 2015. This action involves no stock split of any kind.

Market Maker Surveillance Report. EPGL, CMCSA, GILD, YHOO, MSFT, VALE, Bearishly Biased Price Friction For Wednesday, September 17th 2014
M2 - Thu Sep 18, 3:25AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4737 companies with "abnormal" market making, 2409 companies with positive Friction Factors and 2599 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. EP GLOBAL COMMUNICATIONS INC (OTC:EPGL), Comcast Corp (NASDAQ:CMCSA), GILEAD SCIENCES, INC. (NASDAQ:GILD), Yahoo! Inc (NASDAQ:YHOO), MICROSOFT CORPORATION (NASDAQ:MSFT), Vale SA (NYSE:VALE). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
YHOO: 36.48 (+0.41), GILD: 95.83 (-0.26), VALE: 4.88 (+0.40), MSFT: 54.31 (-0.11), CMCSA: 61.44 (-0.16)

Market Maker Surveillance Report. CICI, EPGL, WEN, PFE, GE, AVNR, Highest Net Buy Volume With Lowest Price Friction For Monday, September 15th 2014
M2 - Tue Sep 16, 5:59AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4654 companies with "abnormal" market making, 1512 companies with positive Friction Factors and 3686 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Monday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Communication Intelligence Corp (OTC:CICI), EP GLOBAL COMMUNICATIONS INC (OTC:EPGL), Wendy's Company (NASDAQ:WEN), Pfizer Inc (NYSE FE), General Electric Co (NYSE:GE), Avanir Pharmaceuticals Inc (NASDAQ:AVNR). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
AVNR: 16.96 (unch), GE: 30.71 (-0.08), PFE: 31.89 (-0.61), WEN: 11.07 (+0.11)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 316

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 0

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Stretch Zone Expands Horizons with Canadian Studio Launch

Updated Category News Views 214

Stretch Zone's Exciting New Chapter in Canada Stretch Zone, a trailblazer in the realm of assisted stretching, has embarked on a significant milestone by opening its first studio in Canada. This new location is not just a store but a powerful symbol of the brand's commitment to enhance flexibility and mobility in communities beyond the United States. The Vision Behind the...

Continue Reading
Eilean Therapeutics Unveils Groundbreaking JAK2 Inhibitor ZE74-0282

Updated Category News Views 585

New Frontiers in JAK2 Inhibition by Eilean Therapeutics Eilean Therapeutics LLC, a pioneering biotechnology company, is set to make waves in cancer treatment with its latest development, ZE74-0282, a wild-type-sparing JAK2-JH2/V617F inhibitor. The company has announced an exciting presentation at the upcoming American Society of Hematology (ASH) Annual Meeting, focusing...

Continue Reading
PodcastOne Extends LadyGang Contract as It Approaches 1000 Episodes

Updated Category News Views 116

PodcastOne Renews its Agreement with LadyGang Podcast PodcastOne, a key player in the podcasting world, is thrilled to announce the renewal of its contract with the immensely popular LadyGang podcast, hosted by Keltie Knight, Becca Tobin, and Jac Vanek. Launched in 2015 on PodcastOne, this engaging podcast has resonated with millions of listeners and is gearing up to...

Continue Reading
BCA Research Warns Upcoming Rate Cuts May Be Insufficient

Updated Category News Views 73

BCA Research Warns Rate Cuts May Arrive Too Late BCA Research has expressed concerns about the upcoming rate cuts, suggesting they might not effectively address a potential recession. The firm points out that the effects of monetary policy often lag, meaning the economy is still grappling with the repercussions of previous tightening measures. Market Sentiments and...

Continue Reading
SOMOS Pilates Nashville: A Vibrant Rebranding Journey

Updated Category News Views 235

SOMOS Pilates Nashville: A Vibrant Rebranding Journey In an inspiring shift, Studio Pilates Nashville has announced its rebranding as SOMOS Pilates Nashville. This transition marks a significant evolution, aimed at celebrating the studio's growth and commitment to community-centered movement practices. Welcoming a New Identity The rebranding initiative reveals more than...

Continue Reading